RecruitingHealthcare ProvidersPostpartum
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
Sponsor: Assistance Publique - Hôpitaux de Paris
You may qualify if…
- ✓ For patients:
- ✓ 1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:
- ✓ Individuals aged 18 years or older,
- ✓ Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
- ✓ Individuals eligible for pneumococcal vaccination against according to current French recommendations,
- ✓ Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
- ✓ 2. For the assessment of pertussis vaccination among pregnant women:
- ✓ Women aged 18 years or older,
You may not qualify if…
- ✕ Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).
Source: ClinicalTrials.gov · NCT07243236 · last updated 2026-04-08